- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Amicus Therapeutics Inc+ Add to Watchlist
FOLD:US3.4000 USD 0.0200 0.58%
As of 20:10:00 ET on 05/24/2013.
Company Profile for Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
Amicus Therapeutics Inc
Key Executives for Amicus Therapeutics Inc (FOLD)
|John F CrowleyChairman/CEO||William D Baird III "Chip"Chief Financial Officer|
|David J LockhartChief Scientific Officer||Bradley L CampbellChief Business Officer|
|Peter M MacalusoVP/Secretary/Counsel||John R KirkVP:Regulatory Affairs|
|Ken ValenzanoVP:Pharmacology||Kenneth W PeistVP:Intellectual Property|
|Enrique DiloneVP:Technical Operations||Daphne QuimiController|